Related Experiment Video

Updated: Jun 2, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

[Chronic necrotizing pulmonary aspergillosis as a complication of silicosis]

J J Blanco1, F J González Barcala, M A Alvarez Moure

  • 1Servicio Neumología, Hospital Meixoeiro, Complexo Hospitalario Universitario de Vigo, Spain. josejesus.blanco.perez@sergas.es

Anales Del Sistema Sanitario De Navarra
|May 3, 2011
PubMed

Insights

Pulmonary aspergillosis is a rare complication in patients with silicosis and progressive massive fibrosis (PMF). Diagnosis is challenging due to its similarity to tuberculosis and cancer.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Occupational Medicine

Background:

  • Chronic necrotizing pulmonary aspergillosis (CNPA) is uncommon, typically affecting individuals with underlying lung disease or mild immunosuppression.
  • Silicosis, a progressive lung disease from silica dust exposure, presents diagnostic challenges for co-existing conditions.

Observation:

  • This report details three cases of pulmonary aspergillosis complicating progressive massive fibrosis (PMF) in patients with a history of silica dust exposure.
  • The clinical presentation and radiological findings of these cases were reviewed.

Findings:

  • Pulmonary aspergillosis is an exceptional complication of silicosis, often mimicking more common conditions like tuberculosis and lung cancer.
  • Diagnostic difficulty arises from the overlapping clinical and radiological features.

Implications:

  • Early recognition and diagnosis of pulmonary aspergillosis in silicosis patients are crucial for effective management.
  • Further research into diagnostic strategies and treatment protocols for this rare complication is warranted.

More Related Videos

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...